PKD1 and autosomal dominant polycystic kidney disease: However, despite success in preclinical murine Pkd1 deficient ADPKD [123], clinical trials of sirolimus and everolimus failed to demonstrate a clinically significant benefit in human ADPKD [120,121,122].